Heart failure 3 Flashcards
(60 cards)
What are the renin-angiotensin system inhibitors used for managing heart failure with reduced ejection fraction (HFrEF)?
The renin-angiotensin system inhibitors used for HFrEF are:
- angiotensin-receptor neprilysin inhibitor (ARNI) sacubitril+valsartan
- angiotensin converting enzyme inhibitors (ACEIs)
- angiotensin II receptor blockers (ARBs)
These medications improve symptoms and reduce cardiovascular mortality and hospitalisation for heart failure.
When should a renin-angiotensin system inhibitor be started in patients diagnosed with HFrEF?
A renin-angiotensin system inhibitor should be started at diagnosis or within 2 to 4 weeks of diagnosis of HFrEF.
This initiation should occur alongside a beta blocker, mineralocorticoid receptor antagonist, and sodium-glucose co-transporter 2 inhibitor.
How does sacubitril+valsartan compare to ACEIs in terms of effectiveness for symptomatic HFrEF?
Sacubitril+valsartan is more effective in reducing the risk of death and hospitalisation for heart failure compared to ACEI in symptomatic HFrEF patients.
However, sacubitril+valsartan is more likely to cause symptomatic hypotension.
What should be substituted if a patient with persistent HFrEF is on an ACEI or ARB?
Substitute with sacubitril+valsartan (ARNI)
Do not use more than one renin-angiotensin system inhibitor concurrently.
What should be monitored in patients taking a renin-angiotensin system inhibitor?
Hypotension, kidney impairment, and hyperkalaemia
An asymptomatic fall in blood pressure or a small rise in serum creatinine or serum potassium can occur when therapy is started or the dose is increased.
What may occur when therapy with a renin-angiotensin system inhibitor is initiated?
An asymptomatic fall in blood pressure or a small rise in serum creatinine or serum potassium
These changes may be transient and should not necessarily prompt dose reduction or cessation.
the risk of first dose hypotension is increased in patients with severely acutely decompensated heart failure but is minimised by starting therapy with a low dose
True or False: An ARB can be used concurrently with an ACEI.
False
Only one renin-angiotensin system inhibitor should be used at a time.
Fill in the blank: An ARB is usually used if an ACEI or _______ is not tolerated.
sacubitril+valsartan (ARNI)
list some ACE inhibitor examples
captopril
enalapril
fosinopril
lisinopril
perindopril (arginine or erbumine)
quinapril
list some ARBs
candesartan
eprosartan
irbesartan
losartan
olmesartan
telmisartan
valsartan
examples of beta blockers approved for heart failure
Beta blockers that improve clinical outcomes in HFrEF are
bisoprolol
carvedilol
metoprolol succinate
nebivolol
Patients already taking a different beta blocker for a comorbidity (eg angina, hypertension) should be switched to one of these heart failure–specific beta blockers.
why does beta-blocker therapy initially worsen symptoms in heart failure?
Blocking sympathetic nervous system support for the failing heart
When should beta-blocker therapy not be started?
During a period of acute decompensation or if the patient has signs of congestion
How often should a patient’s weight be measured during beta-blocker therapy?
Daily
What can the combination of a mineralocorticoid receptor antagonist and a renin-angiotensin system inhibitor cause in patients with kidney impairment?
Life-threatening hyperkalaemia
What should be considered when treating patients with kidney impairment using mineralocorticoid receptor antagonists?
Starting with a lower dose
Lower doses help mitigate the risk of adverse effects such as hyperkalaemia.
What may occur when therapy with a mineralocorticoid receptor antagonist is initiated or the dose is increased?
A small rise in serum potassium
This rise is typically within the normal range and may be transient, and should not necessarily prompt dose reduction or cessation
What is the mechanism of action of ACE inhibitors?
Block conversion of angiotensin I to angiotensin II and inhibit the breakdown of bradykinin, leading to reduced angiotensin II mediated vasoconstriction, sodium retention and aldosterone release.
ACE inhibitors improve heart failure outcomes by reducing vascular resistance and fluid retention.
What is a common side effect of ACE inhibitors?
Dry annoying cough.
This side effect is frequently reported by patients taking ACE inhibitors.
What is a rare but serious side effect of ACE inhibitors?
Angioedema.
Occurs in 0.1-1% of patients taking ACE inhibitors.
In what condition should ACE inhibitors be avoided?
Bilateral renal artery stenosis (or unilateral to single functioning kidney).
List some drugs classified as ACE inhibitors.
- captopril
- enalapril
- fosinopril
- lisinopril
- perindopril
- quinapril
- ramipril
- trandolapril
What is the mechanism of action of heart failure beta blockers?
Competitively block beta receptors in heart and peripheral vasculature to reduce heart rate, blood pressure, and cardiac contractility.
What are potential safety issues associated with heart failure beta blockers?
- Hypotension
- Dizziness
- Worsening of heart failure
these are transient effects and can be minimised through slow dose titration